These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-001384-30 Standard vs reduced dose naloxone for the reversal of opiate overdose. Does dose modification increase the likelihood of reaching hospital and entering a substance misuse programme? not-yet-due
Ongoing 2009-016716-20 Better targeting of antidepressants in older people: the influence of age and genetic background on serotonin signalling not-yet-due
Ongoing 2010-023254-36 Is a short course of azithromycin effective in the treatment of mild to moderate pelvic inflammatory disease (PID)? not-yet-due
Ongoing 2011-003530-13 Randomised phase II window study of short-term preoperative treatment with the PI3K inhibitor GDC-0941 plus Anastrozole versus Anastrozole alone in patients with ER-positive primary breast cancer not-yet-due
Not reported 2011-003695-36 Is intravenous iron and darbepoetin more effective than oral iron in reducing blood transfusion requirements for patients undergoing cardiac surgery 2012-08-20 due-trials
Not reported 2011-004078-26 A double blind placebo controlled randomised trial to study the effects of birch pollen specific immunotherapy (BP-SIT) on the symptoms of the oral allergy syndrome in adult patients. 2017-01-31 due-trials
Not reported Terminated 2012-000594-24 An open study to investigate the effects of injection immunotherapy on allergen-specific T and B cell responses in adult patients with seasonal allergic rhinitis. 2012-08-24 due-trials
Ongoing 2013-002845-12 An international multicentre open-label comparative therapeutic exploratory trial to investigate the role of a new neonatal formulation of dobutamine in the treatment of haemodynamic insufficiency in ... not-yet-due
No trial status on register 2014-001978-33 How can we optimise inhaled beta2 agonist dose as 'reliever' medicine for wheezy pre-school children? bad-data
Ongoing 2017-004141-24 A phase IV, open-label pilot study investigating non-invasive markers of hepatic fibrosis in people living with HIV-1 and non-alcoholic fatty liver disease randomised to receiving optimised background... not-yet-due